Matches in SemOpenAlex for { <https://semopenalex.org/work/W2600264023> ?p ?o ?g. }
- W2600264023 endingPage "2968" @default.
- W2600264023 startingPage "2957" @default.
- W2600264023 abstract "The aim of the present study was to compare the phosphatidylinositol 3-kinase (PI3KCA)-AKT serine/threonine kinase (AKT) pathway in circulating tumor cells (CTCs) and corresponding cancerous tissues. Stemness‑like circulating tumor cells (slCTCs) and CTCs in epithelial-mesenchymal transition (EMT) have been implicated as the active source of metastatic spread in breast cancer (BC). In this regard, the PI3KCA‑AKT signaling pathway was demonstrated to be implicated in and to be frequently mutated in BC. The present study compared this pathway in slCTCs/CTCs in EMT and the corresponding tumor tissues of 90 metastatic BC patients (pts). slCTCs and CTCs in EMT were isolated using the AdnaTest EMT-1/StemCell for the detection of aldehyde dehydrogenase 1 family member A1 (ALDH1) (singleplex PCR) and PI3KCA, AKT2 and twist family bHLH transcription factor 1 (multiplex PCR). Tumor tissue was investigated for PI3KCA hotspot mutations using Sanger sequencing of genomic DNA from micro‑dissected formalin‑fixed paraffin‑embedded tissue, and for the expression of ALDH1 and phosphorylated AKT (pAKT), and phosphatase and tensin homolog (PTEN) loss, by immunohistochemistry. slCTCs were identified in 23% of pts (21/90 pts) and CTCs in EMT in 56% (50/90 pts) of pts. pAKT and ALDH1 positivity in tumor tissue was identified in 47 and 9% of cases, respectively, and a PTEN loss was observed in 18% of pts. A significant association was detected between pAKT expression in cancerous tissue and AKT2 expression in CTCs (P=0.037). PI3KCA mutations were detected in 32% of pts, most frequently on exons 21 (55%) and 10 (45%). Pts with PI3KCA mutations in tumor tissue had a significantly longer overall survival than pts with wild-type PI3KCA expression (P=0.007). Similar results were obtained for pts with aberrant PI3KCA signaling in CTCs and/or aberrant signaling in cancerous tissue (P=0.009). Therapy‑resistant CTCs, potentially derived from the primary tumor or metastatic tissue, may be eliminated with specific PI3K pathway inhibitors, alone or in combination, to improve the prognosis of metastatic BC pts." @default.
- W2600264023 created "2017-04-07" @default.
- W2600264023 creator A5003887595 @default.
- W2600264023 creator A5006753131 @default.
- W2600264023 creator A5016579615 @default.
- W2600264023 creator A5021298305 @default.
- W2600264023 creator A5032378325 @default.
- W2600264023 creator A5036837962 @default.
- W2600264023 creator A5040331693 @default.
- W2600264023 creator A5052434013 @default.
- W2600264023 creator A5072449150 @default.
- W2600264023 creator A5080104306 @default.
- W2600264023 creator A5089812991 @default.
- W2600264023 date "2017-03-30" @default.
- W2600264023 modified "2023-10-17" @default.
- W2600264023 title "Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer" @default.
- W2600264023 cites W1552497335 @default.
- W2600264023 cites W1605218581 @default.
- W2600264023 cites W1912234690 @default.
- W2600264023 cites W1968328642 @default.
- W2600264023 cites W1971843650 @default.
- W2600264023 cites W1974504182 @default.
- W2600264023 cites W1977041021 @default.
- W2600264023 cites W1982191917 @default.
- W2600264023 cites W1985748412 @default.
- W2600264023 cites W1989141849 @default.
- W2600264023 cites W1992477322 @default.
- W2600264023 cites W1993145468 @default.
- W2600264023 cites W1997006452 @default.
- W2600264023 cites W1999065747 @default.
- W2600264023 cites W2003982930 @default.
- W2600264023 cites W2013831759 @default.
- W2600264023 cites W2014691022 @default.
- W2600264023 cites W2016211783 @default.
- W2600264023 cites W2016450639 @default.
- W2600264023 cites W2020149811 @default.
- W2600264023 cites W2023316892 @default.
- W2600264023 cites W2032227988 @default.
- W2600264023 cites W2044702943 @default.
- W2600264023 cites W2054822521 @default.
- W2600264023 cites W2055498399 @default.
- W2600264023 cites W2055614052 @default.
- W2600264023 cites W2055831769 @default.
- W2600264023 cites W2058935670 @default.
- W2600264023 cites W2060397137 @default.
- W2600264023 cites W2062187838 @default.
- W2600264023 cites W2076668534 @default.
- W2600264023 cites W2077702574 @default.
- W2600264023 cites W2078358665 @default.
- W2600264023 cites W2082239705 @default.
- W2600264023 cites W2083762829 @default.
- W2600264023 cites W2087861588 @default.
- W2600264023 cites W2095971747 @default.
- W2600264023 cites W2096229729 @default.
- W2600264023 cites W2096283457 @default.
- W2600264023 cites W2098558557 @default.
- W2600264023 cites W2103736766 @default.
- W2600264023 cites W2103808574 @default.
- W2600264023 cites W2105504936 @default.
- W2600264023 cites W2106036365 @default.
- W2600264023 cites W2118934356 @default.
- W2600264023 cites W2118978588 @default.
- W2600264023 cites W2123467807 @default.
- W2600264023 cites W2127392053 @default.
- W2600264023 cites W2127609858 @default.
- W2600264023 cites W2129172946 @default.
- W2600264023 cites W2129242642 @default.
- W2600264023 cites W2131011879 @default.
- W2600264023 cites W2135340303 @default.
- W2600264023 cites W2138736619 @default.
- W2600264023 cites W2139404453 @default.
- W2600264023 cites W2139552047 @default.
- W2600264023 cites W2144957807 @default.
- W2600264023 cites W2145795890 @default.
- W2600264023 cites W2147787153 @default.
- W2600264023 cites W2151258296 @default.
- W2600264023 cites W2152373440 @default.
- W2600264023 cites W2152654745 @default.
- W2600264023 cites W2154692501 @default.
- W2600264023 cites W2155008430 @default.
- W2600264023 cites W2160928966 @default.
- W2600264023 cites W2162901058 @default.
- W2600264023 cites W2165286055 @default.
- W2600264023 cites W2165404212 @default.
- W2600264023 cites W2166464943 @default.
- W2600264023 cites W2167188058 @default.
- W2600264023 cites W2168532710 @default.
- W2600264023 cites W2170061824 @default.
- W2600264023 cites W2170908060 @default.
- W2600264023 cites W2171313040 @default.
- W2600264023 cites W2185621054 @default.
- W2600264023 cites W2262500441 @default.
- W2600264023 cites W2276370059 @default.
- W2600264023 cites W2281972615 @default.
- W2600264023 cites W2295447094 @default.
- W2600264023 cites W2311060994 @default.
- W2600264023 cites W2341308894 @default.
- W2600264023 cites W2401691535 @default.